These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 27896453

  • 1. Management of phosphorus load in CKD patients.
    Taketani Y, Koiwa F, Yokoyama K.
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):27-36. PubMed ID: 27896453
    [Abstract] [Full Text] [Related]

  • 2. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
    Molony DA, Stephens BW.
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
    [Abstract] [Full Text] [Related]

  • 3. Phosphate, Microbiota and CKD.
    Favero C, Carriazo S, Cuarental L, Fernandez-Prado R, Gomá-Garcés E, Perez-Gomez MV, Ortiz A, Fernandez-Fernandez B, Sanchez-Niño MD.
    Nutrients; 2021 Apr 13; 13(4):. PubMed ID: 33924419
    [Abstract] [Full Text] [Related]

  • 4. Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Komaba H, Tanaka M, Fukagawa M.
    Intern Med; 2008 Apr 13; 47(11):989-94. PubMed ID: 18520108
    [Abstract] [Full Text] [Related]

  • 5. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
    Martin KJ, González EA.
    Clin J Am Soc Nephrol; 2011 Feb 13; 6(2):440-6. PubMed ID: 21292848
    [Abstract] [Full Text] [Related]

  • 6. Current concepts and management strategies in chronic kidney disease-mineral and bone disorder.
    Chauhan V, Kelepouris E, Chauhan N, Vaid M.
    South Med J; 2012 Sep 13; 105(9):479-85. PubMed ID: 22948328
    [Abstract] [Full Text] [Related]

  • 7. The role of phosphate-containing medications and low dietary phosphorus-protein ratio in reducing intestinal phosphorus load in patients with chronic kidney disease.
    Li J, Wang L, Han M, Xiong Y, Liao R, Li Y, Sun S, Maharjan A, Su B.
    Nutr Diabetes; 2019 Apr 03; 9(1):14. PubMed ID: 30944300
    [Abstract] [Full Text] [Related]

  • 8. The challenge of controlling phosphorus in chronic kidney disease.
    Cannata-Andía JB, Martin KJ.
    Nephrol Dial Transplant; 2016 Apr 03; 31(4):541-7. PubMed ID: 25770169
    [Abstract] [Full Text] [Related]

  • 9. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
    Hsu CY, Chen LR, Chen KH.
    Int J Mol Sci; 2020 Sep 18; 21(18):. PubMed ID: 32961953
    [Abstract] [Full Text] [Related]

  • 10. [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].
    Jean G, Daugas É, Roth H, Drueke T, Bouchet JL, Hannedouche T, London G, Fouque D.
    Nephrol Ther; 2017 Nov 18; 13(6):470-478. PubMed ID: 28843391
    [Abstract] [Full Text] [Related]

  • 11. Mineral and Bone Disorder and Its Association with Cardiovascular Parameters in Chinese Patients with Chronic Kidney Disease.
    Zhou C, Wang F, Wang JW, Zhang LX, Zhao MH.
    Chin Med J (Engl); 2016 Oct 05; 129(19):2275-80. PubMed ID: 27647184
    [Abstract] [Full Text] [Related]

  • 12. Dietary Protein Intake and Bone Across Stages of Chronic Kidney Disease.
    Stremke ER, Biruete A, Hill Gallant KM.
    Curr Osteoporos Rep; 2020 Jun 05; 18(3):247-253. PubMed ID: 32240477
    [Abstract] [Full Text] [Related]

  • 13. Circadian rhythms of mineral metabolism in chronic kidney disease-mineral bone disorder.
    Egstrand S, Olgaard K, Lewin E.
    Curr Opin Nephrol Hypertens; 2020 Jul 05; 29(4):367-377. PubMed ID: 32452917
    [Abstract] [Full Text] [Related]

  • 14. Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics.
    Pazianas M, Miller PD.
    Am J Kidney Dis; 2021 Oct 05; 78(4):582-589. PubMed ID: 33774081
    [Abstract] [Full Text] [Related]

  • 15. [Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].
    Iwashita Y, Iwashita Y, Ito T, Shigematsu T.
    Clin Calcium; 2016 Feb 05; 26(2):259-67. PubMed ID: 26813506
    [Abstract] [Full Text] [Related]

  • 16. [Chronic kidney disease and nutrition].
    Yoshida T, Kumagai H.
    Clin Calcium; 2016 Mar 05; 26(3):369-74. PubMed ID: 26923973
    [Abstract] [Full Text] [Related]

  • 17. Women and CKD-mineral and bone disorder.
    Ho LT, Sprague SM.
    Adv Chronic Kidney Dis; 2013 Sep 05; 20(5):423-6. PubMed ID: 23978548
    [Abstract] [Full Text] [Related]

  • 18. [Bone and Nutrition. Nutrition care of renal osteodystrophy].
    Tanaka S, Ito M.
    Clin Calcium; 2015 Jul 05; 25(7):1057-62. PubMed ID: 26119320
    [Abstract] [Full Text] [Related]

  • 19. Dietary Phosphorus as a Marker of Mineral Metabolism and Progression of Diabetic Kidney Disease.
    Winiarska A, Filipska I, Knysak M, Stompór T.
    Nutrients; 2021 Feb 27; 13(3):. PubMed ID: 33673618
    [Abstract] [Full Text] [Related]

  • 20. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Neven E, Vervaet B, Brand K, Gottwald-Hostalek U, Opdebeeck B, De Maré A, Verhulst A, Lalau JD, Kamel S, De Broe ME, D'Haese PC.
    Kidney Int; 2018 Jul 27; 94(1):102-113. PubMed ID: 29716795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.